PORTLAND, OR, UNITED STATES, January 31, 2025 /EINPresswire / -- The global heparin market is experiencing substantial growth as demand for effective anticoagulant therapies increases worldwide.

After more than 70 years of effective clinical use, heparin remains the most common anticoagulant in use and one of the most commonly prescribed drugs to hospitalized patients. However ...

There are anticoagulants such as warfarin, heparin, and new oral medications like rivaroxaban and apixaban. These have been widely applied in patients with atrial fibrillation, a clinical ...

As a highly potent, natural anticoagulant, heparin is well known as an antithrombotic agent, and it has been shown to inhibit smooth muscle cell proliferation. INTERGARD Heparin grafts incorporate ...

Unfractionated heparin is the preferred anticoagulant for use in most of these patients. Conclusion: Newer anticoagulants should be used with caution in patients with mild-to-moderate renal ...

Novartis has brought abelacimab back into the fold. Six years after spinning the asset out to form Anthos Therapeutics, ...

Aplagon, a clinical stage biopharmaceutical company developing a first-in-class therapeutic for thrombo-inflammatory diseases, known as APAC, a heparin proteoglycan mimetic with antiplatelet and ...

Aplagon, a clinical stage biopharmaceutical company developing a first-in-class therapeutic for thrombo-inflammatory diseases, known as APAC, a heparin proteoglycan mimetic with antiplatelet and ...

Pedraza-Cruz, P. , Varghese, M. , DiGiacomo, D. , Spencer, C. and Horani, O. (2025) Adrenal Crisis Secondary to Bilateral Adrenal Hemorrhage in a Patient with Hypercoagulable Disorder. Case Reports in ...

Pregnancy brings dramatic changes to a woman's vascular system, with potentially serious health implications for both mother ...

Researchers have made a groundbreaking discovery in the field of hematology, providing an explanation for spontaneous and unusual blood-clotting that continues to occur despite treatment with ...